Neion Bio raises $23.0M Series A (United States, Jun 2026)

Neion Bio Raises Oversubscribed $23 Million Series A to Advance Biologics Manufacturing Platform and Expand Pipeline - BioSpace

Neion Bio is a biotechnology company focused on revolutionizing the production of biologic medicines using advanced genetic engineering techniques. The company targets the pharmaceutical industry, providing innovative solutions for biologics manufacturing through its unique platform that utilizes chicken eggs as production vessels. This funding round will help expand its pipeline and enhance its manufacturing capabilities.

Neion Bio Raises Oversubscribed $23 Million Series A to Advance Biologics Manufacturing Platform and Expand Pipeline  BioSpace